Active Ingredient: SALMETEROL XINAFOATE
Proprietary Name: SEREVENT
Dosage Form; Route of Administration: POWDER; INHALATION
Strength: EQ 0.05MG BASE/INH
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N020692
Product Number: 001
Approval Date: Sep 19, 1997
Applicant Holder Full Name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY LTD ENGLAND
Marketing Status:
Prescription
Patent and Exclusivity Information
